13 Wolf DM, Jordan VC. The estrogen receptor from tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain. Breast Cancer Res Treat, 1994，31:129-138．
14 Karnik PS, Kulkarni S, Liu XP, et al. Estrogen receptor mutations in tamoxifen-resistant breast cancer. Cancer Res, 1994， 54:349-353．
15 Roodi N, Bailey LR, Kao WY, et al. Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J Natl Cancer Inst, 1995，87:446-451．
16 Fuqua SA, Fitzgerald SD, Chamness GC, et al. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res, 1991，51:105-109．
17 Fuqua SA, Wolf DM. Molecular aspects of estrogen receptor variants in breast cancer. Breast Cancer Res Treat, 1995，35: 233-241．
18 Dotzlaw H, Alkhalaf M, Murphy LC. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol, 1992，6:773-785．
19 Fuqua SA, Fitzgerald SD, Allred DC, et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res, 1992，52: 483-486．
